# FDA Inspection 1156779 - Gingi-Pak A Division of the Belport Co., Inc - November 12, 2021

Source: https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/17be2adc-9eae-4e94-9044-e54d22235c56
Source feed: FDA_Inspections

> FDA Inspection 1156779 for Gingi-Pak A Division of the Belport Co., Inc on November 12, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1156779
- Company Name: Gingi-Pak A Division of the Belport Co., Inc
- Inspection Date: 2021-11-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1082109 - 2019-01-23](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/31574fec-7816-420f-af35-49205b969b36)
- [FDA Inspection 1082109 - 2019-01-23](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/b99dbe38-0c87-4429-a275-7187450019ac)
- [FDA Inspection 896678 - 2014-09-30](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/23cb3321-acdd-4c72-be21-63c38727a54f)
- [FDA Inspection 896678 - 2014-09-30](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/07ac165c-5ce2-42bb-8540-d7ae0244c2f7)
- [FDA Inspection 775564 - 2012-03-14](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/008c1281-09ee-4dfe-8773-772540db8d5b)

Company: https://www.keypedia.com/companies/gingi-pak-a-division-of-the-belport-co-inc/bd9c5700-b0b8-47ae-b992-bef080ddd49e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c